CAR T-Cell Therapy Nearly Eliminates Tumors in All Relapsed or Refractory Myeloma Patients in Phase 1 Trial
Updated results from an ongoing Phase 1 clinical study of bb2121, an investigational therapy for the treatment of multiple…
Updated results from an ongoing Phase 1 clinical study of bb2121, an investigational therapy for the treatment of multiple…